Skip to content
Screener

10x Genomics, Inc. TXG Other income, net (Note 6)

Other income, net (Note 6) at other companies

Bruker logo
BrukerBRKR
$24.6M+316%
Illumina logo
IlluminaILMN
$15M-86.0%
Quanterix Corporation logo
Quanterix CorporationQTRX
-$239K-588%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$24.2M-34.9%
TEC
Bio-TechneTECH
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense):
Interest income4,7974,2719,8117,957
Interest expense(3)(3)
Other income (expense), net(3,887)2,603(4,702)4,739
Total other income9106,8715,10912,693
Income (loss) before provision for income taxes(18,645)36,997(31,492)3,491
Provision for (benefit from) income taxes(714)2,459(91)3,311
Net income (loss)$(17,931)$34,538$(31,401)$180

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s other income, net (note 6)?
10x Genomics, Inc. (TXG) reported other income, net (note 6) of -$3.89M in Q2 2026.
How has 10x Genomics, Inc.'s other income, net (note 6) changed year-over-year?
10x Genomics, Inc.'s other income, net (note 6) decreased by 249.3% year-over-year, from $2.6M to -$3.89M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about 10x Genomics, Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude